Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Z-Ala-Ala-Asp-CMK

Copy Product Info
😃Good
Catalog No. T80745Cas No. 183284-21-1
Alias Z-AAD-CMK

Z-Ala-Ala-Asp-CMK (Z-AAD-CMK) is a selective granzyme B inhibitor that blocks granzyme B protease activity, suitable for studies in inflammatory diseases and tumours.

Z-Ala-Ala-Asp-CMK

Z-Ala-Ala-Asp-CMK

Copy Product Info
😃Good
Purity: 99.96%
Catalog No. T80745Alias Z-AAD-CMKCas No. 183284-21-1
Z-Ala-Ala-Asp-CMK (Z-AAD-CMK) is a selective granzyme B inhibitor that blocks granzyme B protease activity, suitable for studies in inflammatory diseases and tumours.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$123-In Stock
5 mg$297-In Stock
10 mg$496-In Stock
25 mg$793-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.96%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Z-Ala-Ala-Asp-CMK (Z-AAD-CMK) is a selective granzyme B inhibitor that blocks granzyme B protease activity, suitable for studies in inflammatory diseases and tumours.
In vitro
In the co-culture system of normal Homo sapiens keratinocytes and CD8⁺ T cells, treatment with 10 ng/mL Z-Ala-Ala-Asp-CMK for 72 hours can block granzyme B-mediated IL-18 activation and IFN-γ secretion [1].
In the model where OSC-3 cells were pre-treated with anticancer drugs or γ-rays before co-culture with LAK cells, treatment with 50 μM Z-Ala-Ala-Asp-CMK for 18 hours induced DNA fragmentation while suppressing Caspase-3 activity and ROS generation [2].
SynonymsZ-AAD-CMK
Chemical Properties
Molecular Weight441.86
FormulaC19H24ClN3O7
Cas No.183284-21-1
Smiles[C@@H](NC([C@@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)C)=O)C)=O)(C(CCl)=O)CC(O)=O
SequenceZ-Ala-Ala-Asp-CMK
Sequence ShortZ-AAD-CMK
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (181.05 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2632 mL11.3158 mL22.6316 mL113.1580 mL
5 mM0.4526 mL2.2632 mL4.5263 mL22.6316 mL
10 mM0.2263 mL1.1316 mL2.2632 mL11.3158 mL
20 mM0.1132 mL0.5658 mL1.1316 mL5.6579 mL
50 mM0.0453 mL0.2263 mL0.4526 mL2.2632 mL
100 mM0.0226 mL0.1132 mL0.2263 mL1.1316 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Z-Ala-Ala-Asp-CMK | purchase Z-Ala-Ala-Asp-CMK | Z-Ala-Ala-Asp-CMK cost | order Z-Ala-Ala-Asp-CMK | Z-Ala-Ala-Asp-CMK chemical structure | Z-Ala-Ala-Asp-CMK in vitro | Z-Ala-Ala-Asp-CMK formula | Z-Ala-Ala-Asp-CMK molecular weight